Colorectal and pancreatic cancer rates up 10% in last 30 years, major study reveals

by Spink HealthCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The results of a major study across 195 countries, presented today at UEG Week Barcelona 2019, indicate

Updated on: May 21,2024

Colorectal and pancreatic cancer rates up 10% in last 30 years, major study reveals

by Spink HealthCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The results of a major study across 195 countries, presented today at UEG Week Barcelona 2019, indicate

Updated on:May 21,2024

Leukemia spread fueled by messenger particles, shows study

byKing Abdullah University of Science and TechnologyMass spectrometry analysis reveals HSPCs-derived exosomes are enriched in proteins involved in adhesion and migration. Proteomics analysis of

Updated on: January 16,2024

Leukemia spread fueled by messenger particles, shows study

byKing Abdullah University of Science and TechnologyMass spectrometry analysis reveals HSPCs-derived exosomes are enriched in proteins involved in adhesion and migration. Proteomics analysis of

Updated on:January 16,2024

New cancer drug candidate targets immune system 'brakes'

by Sarah C.P. Williams,University of ChicagoDesign and synthesis of stapled alpha-helical peptides targeting FOXP3. (A) Human FOXP3 sequence. Residues F214–K263 represent the entirety of a helix

Updated on: January 12,2024

New cancer drug candidate targets immune system 'brakes'

by Sarah C.P. Williams,University of ChicagoDesign and synthesis of stapled alpha-helical peptides targeting FOXP3. (A) Human FOXP3 sequence. Residues F214–K263 represent the entirety of a helix

Updated on:January 12,2024

Medicaid expansion in Southern states associated with earlier and more comprehensive breast cancer treatment

byAmerican College of SurgeonsCredit: Unsplash/CC0 Public DomainPatients diagnosed with invasive breast cancer in a Southern state that expanded access to Medicaid were more likely to receive tr

Updated on: January 02,2024

Medicaid expansion in Southern states associated with earlier and more comprehensive breast cancer treatment

byAmerican College of SurgeonsCredit: Unsplash/CC0 Public DomainPatients diagnosed with invasive breast cancer in a Southern state that expanded access to Medicaid were more likely to receive tr

Updated on:January 02,2024

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks

Updated on: May 13,2024

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

by Dana-Farber Cancer InstituteCredit: CC0 Public DomainResearchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors—known as pNETs—that have dramatically different risks

Updated on:May 13,2024

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical

Updated on: March 12,2024

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical

Updated on:March 12,2024

Researchers to highlight cancer patient, survivor survey on cannabis

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainAs the legalization of medicinal and recreational cannabis becomes more common in localities across the country, so does research on

Updated on: February 01,2024

Researchers to highlight cancer patient, survivor survey on cannabis

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainAs the legalization of medicinal and recreational cannabis becomes more common in localities across the country, so does research on

Updated on:February 01,2024

Doctors are being sexually harassed at work—this needs to stop

by Louise Stone,The ConversationCredit: Unsplash/CC0 Public DomainDominique Leewas training in radiation oncology when she was invited to join her supervisor to discuss a training opportun

Updated on: May 25,2024

Doctors are being sexually harassed at work—this needs to stop

by Louise Stone,The ConversationCredit: Unsplash/CC0 Public DomainDominique Leewas training in radiation oncology when she was invited to join her supervisor to discuss a training opportun

Updated on:May 25,2024

Study identifies new treatment target for metastatic cancer

by Elizabeth Chapin,University of KentuckySuccinate levels are elevated during EMT. (A) Expression of EMT markers was assessed by western blot in control, Snail1- and Twist1-expressing HMLE cell

Updated on: February 18,2024

Study identifies new treatment target for metastatic cancer

by Elizabeth Chapin,University of KentuckySuccinate levels are elevated during EMT. (A) Expression of EMT markers was assessed by western blot in control, Snail1- and Twist1-expressing HMLE cell

Updated on:February 18,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on: February 01,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on:February 01,2024

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on: January 23,2024

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on:January 23,2024

A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

by Tina Hilding,Washington State UniversityNumber of mutations by variant type (A) before filtering and (B) after filtering. (C) Number of genes and their role in cancer. (D) Pie chart showing t

Updated on: September 28,2024

A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

by Tina Hilding,Washington State UniversityNumber of mutations by variant type (A) before filtering and (B) after filtering. (C) Number of genes and their role in cancer. (D) Pie chart showing t

Updated on:September 28,2024